PRN Insider Trading

Insider Ownership Percentage: 8.62%
Insider Buying (Last 12 Months): C$480,476.70
Insider Selling (Last 12 Months): C$0.00

Profound Medical Insider Trading History Chart

This chart shows the insider buying and selling history at Profound Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Profound Medical Share Price & Price History

Current Price: C$10.03
Price Change: Price Increase of +0.03 (0.30%)
As of 12/24/2024 02:21 PM ET

This chart shows the closing price history over time for PRN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Profound Medical Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/10/2024Arun Menawat Dr.DirectorBuy20,000C$10.65C$213,000.00
12/10/2024Thomas Michael TamberrinoSenior OfficerBuy13,333C$10.65C$141,996.45
8/15/2024Rashed Osman DewanSenior OfficerBuy9,765C$12.85C$125,480.25
12/5/2023Mathieu BurtnykSenior OfficerBuy5,447C$14.15C$77,090.30
8/15/2023Arun Menawat Dr.DirectorBuy24,558C$12.95C$318,026.10
8/15/2023Rashed Osman DewanSenior OfficerBuy9,747C$12.95C$126,223.65
12/20/2022Arun Menawat Dr.DirectorBuy13,000C$10.62C$138,020.69425,296
9/7/2022Ken KnudsonSenior OfficerBuy5,000C$7.21C$36,055.5022,700
5/24/2022Arun Menawat Dr.DirectorBuy1,000C$8.38C$8,384.00412,296
5/20/2022Arun Menawat Dr.DirectorBuy2,500C$8.97C$22,425.00411,296
5/18/2022Rashed Osman DewanSenior OfficerBuy4,000C$8.95C$35,800.0014,000
5/12/2022Arun Menawat Dr.DirectorBuy30,516C$8.65C$264,001.24378,796
See Full Table

SEC Filings (Institutional Ownership Changes) for Profound Medical (TSE:PRN)

44.35% of Profound Medical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Profound Medical logo
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.
Read More on Profound Medical

Today's Range

Now: C$10.03
Low: C$10.03
High: C$10.40

50 Day Range

MA: C$10.78
Low: C$9.98
High: C$12.35

52 Week Range

Now: C$10.03
Low: C$9.55
High: C$15.75

Volume

8,850 shs

Average Volume

7,636 shs

Market Capitalization

C$245.53 million

P/E Ratio

N/A

Dividend Yield

0.35%

Beta

0.81

Who are the company insiders with the largest holdings of Profound Medical?

Profound Medical's top insider investors include:
  1. Arun Menawat Dr (Director)
  2. Mathieu Burtnyk (Senior Officer)
  3. Rashed Osman Dewan (Senior Officer)
  4. Thomas Michael Tamberrino (Senior Officer)
Learn More about top insider investors at Profound Medical.